Leeds-based wound specialist Tissue Regenix delivers rise in full year sales as it grows in the US

Wound specialist Tissue Regenix today revealed that its sales rose last year as it invested in its operations in the US.
The annual results will be closely studied by investorsThe annual results will be closely studied by investors
The annual results will be closely studied by investors

Leeds-based Tissue Regenix, which uses animal and human tissue to replace damaged human body parts, has also secured a partnership with a major healthcare company to help it keep growing.

Tissue Regenix Group has published its annual results for the year ended December 31 2019.

Hide Ad
Hide Ad

Over the year the company increased its revenues by 12 per cent to £13.03m and its gross profit rose to £6.02m , from £5.92m the previous year.

The operating loss narrowed to £7.20m from £8.69m the year before.

Over the year, the company strengthened its management team in San Antonio in the US and outsourced some product lines to increase manufacturing capacity.

Over the first quarter of this financial year, revenue increased by 18 per cent year-on-year, despite a cyber attack at the San Antonio facility.

Hide Ad
Hide Ad

A conditional fundraising raised gross proceeds of £14.62m in May and the company has also secured a new strategic collaboration with a top 10 global healthcare company.

US Government backed loans of $1m were secured in April 2020 to help with the US cost base during COVID-19 pandemic

Gareth Jones, the interim CEO of Tissue Regenix Group, commented: "During 2019, recognising the need to optimise our supply chain and processes to address various operational challenges and support the growing demand for our products, we concentrated efforts on implementing a number of efficiency improvements which manifested in donor throughput more than doubling between Q1-Q4 2019 at the facility in San Antonio.

"Despite experiencing manufacturing capacity constraints and operational challenges, these initiatives meant we were able to increase our top-line revenue by 12% year-on-year (8% constant currency)."

Hide Ad
Hide Ad

ITissue Regenix also implemented a number of cost control measures in the fourth quarter of 2019 which will provide annualised savings of around £1m, Mr Jones said.

He added: "We remain committed to assessing our ongoing operational cost base to ensure that funds are deployed in the most efficient manner and efficiencies maximised, as we work towards a position of break-even.

"In May 2020, we undertook a fundraise of £14.62m, subject to approval by shareholders at a general meeting and admission of shares on AIM, to invest in our manufacturing infrastructure to increase this capacity further which will allow us to unlock additional revenues and new partnership opportunities.

"As an example of the exciting growth potential of the business and testament to the strong underlying demand for our portfolio of regenerative biologic products, following the year-end, we announced a strategic partnership with a top 10 global healthcare company for a new product launch.

Hide Ad
Hide Ad

"Additionally, the receipt of CE Mark approval for OrthoPure XT is a significant milestone in the evolution of our product portfolio and corporate objectives.

"We remain confident in our long-term strategy to grow the business. However, whilst sales were not materially impacted during Q1 2020, where we delivered 18 per cent year-on-year growth, the board is unable to provide clarity on the financial outlook for 2020 until there is greater visibility around the impact of the COVID-19 pandemic in the market."

Editor’s note: first and foremost - and rarely have I written down these words with more sincerity - I hope this finds you well.

Almost certainly you are here because you value the quality and the integrity of the journalism produced by The Yorkshire Post’s journalists - almost all of which live alongside you in Yorkshire, spending the wages they earn with Yorkshire businesses - who last year took this title to the industry watchdog’s Most Trusted Newspaper in Britain accolade.

Hide Ad
Hide Ad

And that is why I must make an urgent request of you: as advertising revenue declines, your support becomes evermore crucial to the maintenance of the journalistic standards expected of The Yorkshire Post. If you can, safely, please buy a paper or take up a subscription. We want to continue to make you proud of Yorkshire’s National Newspaper but we are going to need your help.

Postal subscription copies can be ordered by calling 0330 4030066 or by emailing [email protected]. Vouchers, to be exchanged at retail sales outlets - our newsagents need you, too - can be subscribed to by contacting subscriptions on 0330 1235950 or by visiting www.localsubsplus.co.uk where you should select The Yorkshire Post from the list of titles available.

If you want to help right now, download our tablet app from the App / Play Stores. Every contribution you make helps to provide this county with the best regional journalism in the country.

Sincerely. Thank you.

James Mitchinson

Editor